BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2235811)

  • 1. Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.
    Karmali R; Barker S; Hewison M; Fraher L; Katz DR; O'Riordan JL
    Postgrad Med J; 1990 Sep; 66(779):757-60. PubMed ID: 2235811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal vitamin D metabolism in Hodgkin's lymphoma.
    Davies M; Mawer EB; Hayes ME; Lumb GA
    Lancet; 1985 May; 1(8439):1186-8. PubMed ID: 2860388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolism in myeloma.
    Lawson-Matthew P; Clayton J; Guilland-Cumming D; Yates A; Preston E; Greaves M; Kanis JA
    Br J Haematol; 1989 Sep; 73(1):57-60. PubMed ID: 2803979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism.
    Cundy T; Haining SA; Guilland-Cumming DF; Butler J; Kanis JA
    Clin Endocrinol (Oxf); 1987 Jun; 26(6):667-74. PubMed ID: 3665123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcaemia in Hodgkin's disease related to prostaglandin synthesis.
    Laforga JB; Vierna J; Aranda FI
    J Clin Pathol; 1994 Jun; 47(6):567-8. PubMed ID: 8063947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
    Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
    Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia, Hodgkin's disease, and calcitriol.
    Needle MA; Chandra B
    Ann Intern Med; 1984 Jun; 100(6):916. PubMed ID: 6547035
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.
    Bolo-Deoku J; Basu S; Lakhani S; Dunne F; Ratcliffe WA; Clarke M; Barron JL
    J Clin Pathol; 1992 Jun; 45(6):541-2. PubMed ID: 1624608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcaemia in Hodgkin's disease.
    Lambrecht L; Boelaert J; Louwagie A; Criel A; Daneels R; Bouillon R
    Acta Clin Belg; 1986; 41(1):37-42. PubMed ID: 3754677
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemia due to vitamin D-secreting hodgkin's lymphoma exacerbated by oral calcium supplementation.
    Gupta R; Neal JM
    Endocr Pract; 2006; 12(2):227-9. PubMed ID: 16690471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
    Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
    Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?
    Rieke JW; Donaldson SS; Horning SJ
    Cancer; 1989 May; 63(9):1700-7. PubMed ID: 2649225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin's lymphoma.
    Schaefer K; Saupe J; Pauls A; von Herrath D
    Klin Wochenschr; 1986 Jan; 64(2):89-91. PubMed ID: 3754025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
    Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
    Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
    Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
    Gates S; Shary J; Turner RT; Wallach S; Bell NH
    J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ratio of serum levels of 1,25-dihydroxyvitamin D3 and parathyroid hormone for the diagnosis and treatment of tuberculous peritonitis in a chronic kidney disease patient: a case report].
    Oka H; Miishima N; Yoshitomi R; Mizobuchi T; Kamimura T; Sugawara K; Harada A
    Nihon Jinzo Gakkai Shi; 2010; 52(5):584-9. PubMed ID: 20715591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.